| 000 | 01836 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513070811.0 | ||
| 264 | 0 | _c19940203 | |
| 008 | 199402s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/0360-3016(94)90159-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEarle, J D | |
| 245 | 0 | 0 |
_aEvaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cJan 1994 |
||
| 300 |
_a207-11 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHycanthone _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aFoley, J F | |
| 700 | 1 | _aWieand, H S | |
| 700 | 1 | _aKvols, L K | |
| 700 | 1 | _aMcKenna, P J | |
| 700 | 1 | _aKrook, J E | |
| 700 | 1 | _aTschetter, L K | |
| 700 | 1 | _aSchutt, A J | |
| 700 | 1 | _aTwito, D I | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 28 _gno. 1 _gp. 207-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0360-3016(94)90159-7 _zAvailable from publisher's website |
| 999 |
_c8269725 _d8269725 |
||